NEW YORK (Reuters Health) – Compared with fibrinolytic therapy, primary percutaneous coronary intervention (PCI) in patients with acute MI is associated with a significant reduction in early mortality,…
NEW YORK (Reuters Health) – For patients with high platelet reactivity after percutaneous coronary intervention, treatment with a high-dose clopidogrel regimen does not improve outcomes compared with standard…
NEW YORK (Reuters Health) — Patients with chronic kidney disease (CKD) who are administered sodium bicarbonate before emergency coronary procedures might be less likely to suffer contrast-induced nephropathy…
NEW YORK (Reuters Health) – Encouraging results with total arch replacement combined with stented “elephant trunk” implantation suggest that this strategy should become a new standard of management…
Lena Edwards, MD, internist, Balance Health & Wellness Center, discusses salivary cortisol testing which is increasingly being used in the diagnosis and treatment of patients with hypothalamic pituitary…
Lena Edwards, MD, internist, Balance Health & Wellness Center, discusses stressand cardiovascular disease. Cortisol has effects in causing disease over the long-term. It lowers growth hormone levels, increases…
NEW YORK (Reuters Health) – Even with routine use of stents and thienopyridines such as clopidogrel for elective percutaneous coronary intervention, glycoprotein IIb/IIIa inhibitors (GPIs) such as abciximab…
NEW YORK (Reuters Health) – Clopidogrel improves outcomes not only in patients with myocardial infarction undergoing primary percutaneous coronary intervention, but also in MI patients revascularized by coronary…
NEW YORK (Reuters Health) – Combining electrocardiographic P-axis and QRS duration data can provide enhanced criteria for emphysema detection, researchers report in a February 9th on-line paper in…
NEW YORK (Reuters Health) – While carotid artery stenting (CAS) can be performed safely in different hospital settings by a variety of specialists, both site and operator volumes…